Get tips and insights from health-care professionals and people with diabetes, share your thoughts, and ask questions on our blog.
- Alternative Medicine/ Complementary Therapies
- Blood Glucose Monitoring
- Dental Health
- Diabetes News
- Diabetes Research
- Diabetic Complications
- Diagnosis
- Emotional Health
- Exercise
- Eyes & Vision
- Foot Care
- General Diabetes & Health Issues
- Heart Health
- High Blood Glucose
- Insulin & Other Injected Drugs
- Kids & Diabetes
- Living With Diabetes
- Low Blood Glucose
- Men's Health
- Money Matters
- Nutrition & Meal Planning
- Oral Medicines
- Sexual Health
- Tools & Technology
- Traveling With Diabetes
- Type 1 Diabetes
- Type 2 Diabetes
- Weight Loss
- What We're Reading
- Women's Health
Sign up for our weekly e-mail newsletter and receive a FREE GIFT! Enter your e-mail below.
Links to help you learn more about diabetes.
Ask a diabetes expert
Other diabetes resources
Browse article topics
“Swine” Flu Vaccine to be Available Shortly
On September 15, the U.S. Food and Drug Administration (FDA) announced its approval of four vaccines against the H1N1, or “swine” flu, virus. According to federal officials, roughly six to seven million doses of vaccine will be available starting the first week in October, with millions more doses to be shipped in the following weeks…
Lantus and Cancer: Further Study Needed
Late last week, results from several European studies showing a possible link between Lantus (insulin glargine) and cancer were published online in the journal Diabetologia. Health agencies such as the U.S. Food and Drug Administration (FDA) and the International Diabetes Federation (IDF) have been swift in their response to the release of this information, indicating that the studies are not conclusive and that people with diabetes should not stop taking Lantus without speaking to their doctors…
Research on Rosiglitazone
According to research presented at the American Diabetes Association’s 69th Scientific Sessions, using rosiglitazone (brand name Avandia) in combination with metformin or a sulfonylurea does not increase the risk for cardiovascular disease or death in people with Type 2 diabetes. But some scientists have met these results critically, claiming that the study does not have enough statistical power to resolve any of the controversy surrounding this drug.
News Roundup
I’ve been dealing with a bad cold of late, but I’m still keeping an eye on the latest diabetes news. Here are some headlines that have caught my attention recently…
Novel Diabetes Drug Cycloset Approved
Last week, the U.S. Food and Drug Administration (FDA) approved a new drug for treating Type 2 diabetes. Called Cycloset, the drug is actually a new version of the older drug bromocriptine, which has been used at higher doses to treat people with Parkinson disease.
Some Accu-Chek Spirit Pumps Recalled
On April 30, Disetronic Medical Systems, Inc. (a division of Roche) announced a recall of certain Accu-Chek Spirit insulin pumps due to a manufacturing problem: These pumps may be at risk of having their "up" and/or "down" buttons fail with repeated use. Pumps with serial numbers ranging from SN02119552 to SN10006093, which were shipped in the United States, are affected by this recall.
Disclaimer of Medical Advice: You understand that the blog posts and comments to such blog posts (whether posted by us, our agents or bloggers, or by users) do not constitute medical advice or recommendation of any kind, and you should not rely on any information contained in such posts or comments to replace consultations with your qualified health care professionals to meet your individual needs. The opinions and other information contained in the blog posts and comments do not reflect the opinions or positions of the Site Proprietor.
